Cannabidiol seems to have grabbed the world by the throat, and it’s not letting go any time soon. The hemp extract has been in the mainstream for only a few years but it is insanely popular, with experts estimating that the CBD industry will be worth $20 billion by 2024. CBD’s popularity is due to its medicinal properties. Users claim the chemical is effective against a variety of ailments, ranging from high blood pressure and anxiety to chronic pain and insomnia.
The hemp extract affects people differently, based on a variety of factors such as age and metabolism. Gender also affects how CBD will affect you. Hormonal differences, for instance, will influence how CBD will interact with the endocannabinoid system (ESC). This is a nervous system that interacts with cannabinoids made by…
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.